Share this with FacebookShare this with TwitterShare this with LinkedInEmail this pagePrint this page
Gleolan
Saint Luke’s Marion Bloch Neuroscience Institute was the first hospital in the Kansas City area to perform a tumor removal procedure using Gleolan™. This newly-FDA approved, optical imaging agent turns glioma brain tumors bright pink to increase their visibility under a special blue light. Gleolan helps the surgeon more easily identify the full tumor helping ensure more complete tumor removal and a better result for the patient.
Gleolan is one of several treatment options we offer our patients. From radiation and chemotherapy, to minimally invasive surgery, to clinical trials, our neuro-oncology team has all the tools to help our patients battle complex spine and brain tumors.